☆ 3.8 Article

What is the role of CellDetect(R) in detecting and monitoring bladder cancer?

UROLOGIA JOURNAL (2023)

Related references

Note: Only part of the references are listed.

Review Urology & Nephrology

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

Marko Babjuk et al.

Summary: The updated EAU guidelines provide new information on the diagnosis and treatment of NMIBC for clinical practice. Individual risk assessment is crucial in determining the appropriate treatment for patients with different risk levels. Surgical intervention, including radical cystectomy, may be necessary for cases unresponsive to BCG treatment or with high risk of progression.

EUROPEAN UROLOGY (2022)

Add to Collection

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Oncology

Diagnostic value comparison of CellDetect, fluorescent in situ hybridization (FISH), and cytology in urothelial carcinoma

Donghao Shang et al.

Summary: The study found that both CellDetect and FISH have superior sensitivity in diagnosing UC compared to traditional urine cytology, with no significant difference in specificity. CellDetect shows varying sensitivity in different types and grades of UC, making it suitable for monitoring UC recurrence and screening undetectable cases.

CANCER CELL INTERNATIONAL (2021)

Add to Collection

Article Medical Laboratory Technology

Risk of malignancy assessment for theParis Systemfor reporting urinary cytology

Napoleon Moulavasilis et al.

DIAGNOSTIC CYTOPATHOLOGY (2020)

Add to Collection

Review Oncology

Review of non-invasive urinary biomarkers in bladder cancer

Hyung-Ho Lee et al.

TRANSLATIONAL CANCER RESEARCH (2020)

Add to Collection

Review Oncology

Novel urinary biomarkers for the detection of bladder cancer: A systematic review

Wei Shen Tan et al.

CANCER TREATMENT REVIEWS (2018)

Add to Collection

Article Urology & Nephrology

A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study

Noa Davis et al.

EUROPEAN UROLOGY FOCUS (2018)

Add to Collection

Review Urology & Nephrology

Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review

Viktor Soukup et al.

EUROPEAN UROLOGY (2017)

Add to Collection

Article Oncology

Application of the CellDetect® staining technique in diagnosis of human cervical cancer

Song He et al.

GYNECOLOGIC ONCOLOGY (2014)

Add to Collection

Article Urology & Nephrology

A Novel Urine Cytology Stain for the Detection and Monitoring of Bladder Cancer

Noa Davis et al.

JOURNAL OF UROLOGY (2014)

Add to Collection

Review Urology & Nephrology

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers

Ashish M. Kamat et al.

EUROPEAN UROLOGY (2013)

Add to Collection

Article Medical Laboratory Technology

Screening for cervical neoplasia: A community-based trial comparing Pap staining, human papilloma virus testing, and the new bi-functional celldetect® stain

Pavel Idelevich et al.

DIAGNOSTIC CYTOPATHOLOGY (2012)

Add to Collection

Article Pathology

Novel dual-function CellDetect® staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia

Pavel Idelevich et al.

DIAGNOSTIC PATHOLOGY (2010)

Add to Collection

Article Urology & Nephrology

Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder

PI Karakiewicz et al.

BJU INTERNATIONAL (2006)

Add to Collection

Review Urology & Nephrology

Urine markers for bladder cancer surveillance: A systematic review

BWG van Rhijn et al.

EUROPEAN UROLOGY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.